MAUNA KEA TECH news, videos and press releases
For more news please use our advanced search feature.
MAUNA KEA TECH - More news...
MAUNA KEA TECH - More news...
- Mauna Kea Technologies Announces the Transfer of its Shares on the Euronext Growth Paris Market Will Be Effective August 8, 2023
- Mauna Kea Technologies: Monthly information regarding the total number of voting rights and shares comprising the share capital
- Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces the Installation of Cellvizio® at University College Cork - APC Microbiome Ireland for Inflammatory Bowel Disease (IBD) Applications
- Mauna Kea Technologies: Release of the 2022 Universal Registration Document
- Mauna Kea Technologies Announces the Appointment of Côme de La Tour du Pin as its Chief Financial Officer
- Mauna Kea Technologies Announces the Launch of the Transfer of its Shares to Euronext Growth Paris
- Mauna Kea Technologies Announces Results of its 2023 Ordinary and Extraordinary Annual General Meeting
- Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion® with Cellvizio®
- Mauna Kea Technologies Secures an Equity Line Financing With Vester Finance Limited to a Maximum of 11.4% of the Capital
- Proposed Transfer of the Listing of Mauna Kea Technologies’ Shares to the Euronext Growth Paris Market
- Mauna Kea Technologies Announces Sales of €4.2 million for the first quarter of 2023, up 121% from 2022
- Mauna Kea Technologies Reports 2022 Annual Results
- Mauna Kea Technologies Announces the Coverage of Its Stock by Portzamparc – Groupe BNP Paribas
- Mauna Kea Technologies Announces Sales for the Fourth Quarter and Full Year 2022
- Mauna Kea Technologies Announces Its 2023 Financial Calendar
- Mauna Kea Technologies Announces the Publication of Results of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy for Lung Cancer
- Mauna Kea Technologies Reports its Financial Results for the First Half of 2022
- Mauna Kea Technologies and Tasly Pharmaceutical Announce the Incorporation of Joint Venture in China
- Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease (IBD) and its Publication in Gastroenterology
- Mauna Kea Technologies Announces 2022 Nine Month Sales Results
- Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer
- Mauna Kea Technologies Postpones Release of its 2022 Half-Year Financial Results
- On Target Laboratories and Mauna Kea Technologies Further Explore Targeted Detection and Real-Time Diagnosis of Lung Cancer with a Molecular Imaging Agent
- Mauna Kea Technologies Announces Q2 and 1H 2022 Revenues
- Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements
- Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer
- On Target Laboratories and Mauna Kea Technologies Demonstrate Intraprocedural Targeted Detection of Lung Cancer with a Molecular Imaging Agent
- Mauna Kea Technologies Publishes Q1 2022 Sales and Its 2021 Financial Results
